Protein detail

EPOR

Erythropoietin receptor (EPO-R)

Protein symbol
EPOR
UniProt ID
EVMP score
0.38
Frequency
1
Transmembrane count
1
Protein classification
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Erythropoietin receptor (EPO-R)
Protein Function
  • Disease related genes
  • Cancer-related genes:Candidate cancer biomarkers
  • Human disease related genes:Cardiovascular diseases:Hematologic diseases
  • FDA approved drug targets:Biotech drugs
Transmembrane
251..273; Helical
Transmembrane Count
1
Entrez Gene Symbol
Frequency
1
EVMP Score
0.38
Fluorescence & Localization
Tissue Specificblood vesselCell SpecificAdrenal medulla cells
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

15 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
EPORJAK1P23458Y489phosphorylationLi2012
EPORJAK1P23458Y426phosphorylationLi2012
EPORJAK1P23458Y454phosphorylationLi2012
EPORJAK1P23458Y456phosphorylationLi2012
EPORINSRP06213Y489phosphorylationKEAKEA:17570479
Page 2 of 2Previous

Ligand-Receptor Signaling

72 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorCellPhoneDBNoYesYesYesNo
receptorreceptorGO_IntercellNoYesYesYesNo
receptorreceptorHPMRNoYesYesYesNo
receptorreceptorICELLNETNoYesYesYesNo
receptorreceptorCellChatDBNoYesYesYesNo
receptorreceptorCellTalkDBNoYesYesYesNo
receptorreceptorSurfaceomeNoYesYesYesNo
receptorreceptorRamilowski2015NoYesYesYesNo
receptorreceptorKirouac2010NoYesYesYesNo
receptorreceptorGuide2PharmaNoYesYesYesNo
Page 1 of 8Next

Regulatory Interaction Network

6 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
JAK2O60674EPORP19235YesYesNoHPRD_MIMPSIGNORProtMapperHINTPhosphoSite_KEAphosphoELM_KEAPhosphoNetworksHPRDCui2007WangBEL-Large-Corpus_ProtMapperHPRD-phosphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointKEABioGRIDHPRD_KEAphosphoELMCellinkerSIGNOR_ProtMapperSPIKE_LCSPIKEHPRD:8343951Cellinker:9030561HPRD:11779507ProtMapper:12441334KEA:12441334SPIKE:18672044KEA:9573010SIGNOR:12441334KEA:10660611ProtMapper:15212693HINT:30044226KEA:7559499KEA:11443118HINT:8343951KEA:10579919phosphoELM:10579919HPRD:12441334SPIKE:12524467SPIKE_LC:18672044HINT:11779507BioGRID:8343951HPRD-phos:12441334SPIKE_LC:12524467KEA:12027890
EPORP19235JAK2O60674YesYesNoKEGG-MEDICUSHPRDCui2007HINTSignaLink3BioGRIDWangHPRD:12441334HPRD:8343951HINT:8343951HINT:30044226HPRD:11779507HINT:11779507BioGRID:8343951SignaLink3:23331499SignaLink3:8343951SignaLink3:18160720SignaLink3:11779507
EPOP01588EPORP19235YesYesNoiTALKKirouac2010KEGG-MEDICUSGuide2Pharma_LRdbICELLNETSIGNORHINTSignaLink3InnateDBDIPUniProt_LRdbLit-BM-17HPMR_talklrHPMRCellChatDBHPRD_LRdbDLRP_CellinkertalklrscConnectHPRDCui2007IntActDLRP_talklrRamilowski2015_Baccin2019Guide2Pharma_CellinkerWangRamilowski2015HPMR_LRdbCellPhoneDBGuide2Pharma_talklrHPRD_talklrBioGRIDBaccin2019CellinkerSTRING_talklrCellCallGuide2PharmaCellTalkDBFantom5_LRdbHPMR_CellinkerconnectomeDB2020SPIKE_LCLRdbSPIKEHINT:9774108IntAct:29997244Lit-BM-17:15358619SPIKE_LC:17145710SIGNOR:9442088ICELLNET:9974393LRdb:10318834IntAct:9774108Cellinker:10318834Lit-BM-17:8662939Cellinker:16982323DIP:8662939Lit-BM-17:17327410LRdb:9442088Lit-BM-17:10318834Lit-BM-17:9808045BioGRID:9808045BioGRID:17327410LRdb:16982323HINT:9808045connectomeDB2020:9808045Lit-BM-17:9774108HPMR:9442088DIP:9774108HPRD:10318834Lit-BM-17:9030560Guide2Pharma:16982323Baccin2019:9442088Baccin2019:16982323connectomeDB2020:16982323HINT:15358619InnateDB:9774108SignaLink3:9774108SignaLink3:23331499DIP:9030560connectomeDB2020:9442088Cellinker:9442088BioGRID:15358619ICELLNET:2163696scConnect:16982323SPIKE_LC:18586265Baccin2019:10318834InnateDB:21889455HINT:29997244LRdb:9808045SPIKE:18586265Cellinker:9808045HINT:10318834SIGNOR:9774108HPRD:9808045Baccin2019:9808045BioGRID:10318834connectomeDB2020:10318834DIP:10318834
EPORP19235P85AP27986YesYesNoHPRDHINTSignaLink3SPIKE_LCLit-BM-17SignaLink3:7559499Lit-BM-17:7559499HINT:7559499Lit-BM-17:15644415Lit-BM-17:9162069Lit-BM-17:24113870HPRD:7559499SPIKE_LC:16713569SignaLink3:23331499HINT:15644415SignaLink3:9162069
NOSIPQ9Y314EPORP19235YesYesNoSIGNORSIGNOR:12746455
PTN1P18031EPORP19235YesNoYesSPIKE_LCSIGNORIntActDEPODSPIKE_LC:14527337IntAct:14527337SIGNOR:14527337DEPOD:14527337

Protein Complex Composition

6 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
EPO-EPOR complexEPOEPORP01588P192351:2CORUMCompleathu.MAP2SPIKEPDBCORUM:5446PDB:1eerCompleat:HC779PDB:1cn49774108
EPOR receptor complexEPORP192352CORUMPDBPDB:6mohPDB:1ernPDB:1ebaPDB:4y5vPDB:1ebpPDB:6molPDB:4y5yPDB:6moeCORUM:54428662530
Epo-R-IP(3)R type II-TRPC2 complexEPORITPR1ITPR2P19235Q14571Q146431:1:1CompleatCompleat:HC44015329338
EPORJAK2O60674P192354:4PDBPDB:6e2q
EPORQ5NV67P19235Q5NV674:4PDBPDB:4y5x
EPORQ6GMX6Q7Z3Y4P19235Q6GMX6Q7Z3Y43:3:3PDBPDB:2jix

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyMass spectrometry83640649139949490382254533279541438731868273332754034444540311616
Sequence, Structure & Domains

Sequences

Length
508
Mass
55,065
Sequence
MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTHKGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVGSEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGASAASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGLSDGPYSNPYENSLIPAAEPLPPSYVACS
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=EPOR-F; Synonyms=Full-length form; IsoId=P19235-1; Sequence=Displayed; Name=EPOR-S; Synonyms=Soluble form; IsoId=P19235-2; Sequence=VSP_009508, VSP_009509; Name=EPOR-T; Synonyms=Truncated form; IsoId=P19235-3; Sequence=VSP_009510, VSP_009511
Alternative Sequence
196..241; VEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVS -> GTVFLSPDWLSSTRARPHVIYFCLLRVPRPDSAPRWRSWRAAPSVC (in isoform EPOR-S); 242..508; Missing (in isoform EPOR-S); 306..328; LWLYQNDGCLWWSPCTPFTEDPP -> VGGLVVPSVPGLPCFLQPNCRPL (in isoform EPOR-T); 329..508; Missing (in isoform EPOR-T)

3D Structural Models

Turn
99..101; 127..129; 226..228; 245..247; 294..299
Helix
33..45; 111..113; 139..141; 175..177; 250..282; 289..293; 304..311
Beta Strand
47..49; 51..58; 61..67; 76..83; 84..86; 89..91; 93..98; 102..108; 116..118; 120..126; 131..137; 142..144; 149..155; 157..160; 162..167; 169..171; 178..185; 188..190; 195..198; 204..207; 212..224; 240..244; 316..320
3D Structure
NMR spectroscopy (1); X-ray crystallography (21)

Domain & Motif Annotations

Motif
233..237; WSXWS motif; 282..290; Box 1 motif; 452..457; ITIM motif
Domain (CC)
The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.; DOMAIN: The box 1 motif is required for JAK interaction and/or activation.; DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases.
Domain (FT)
147..247; Fibronectin type-III
Region
454..456; Required for high-affinity SOCS3 binding; 467..494; Disordered
Protein Families
  • Type I cytokine receptor family
  • Type 1 subfamily
Sequence Similarities
Belongs to the type I cytokine receptor family. Type 1 subfamily.
Clinical Relevance